“Furthermore, by the same resolution, the Board of Directors of the Company decided to appoint and confirm the continuity of Mrs. Simona Cocoș in capacity as General Manager of the Company starting with March 21, 2023. Mrs. Simona Cocoș will hold and exercise the position as General Manager of the Company during her mandate as member of the Board of Directors (i.e., until 21 March 2027) or for a shorter duration, if the Company decides so, as the case may be,” the report reads.
Simona Cocos took over as Chairperson of the Board of Directors in August 2021, after the termination of the mandate of Nicholas Robert Haggar after stepping down as member and Chairman of the Board of Directors.
Zentiva is controlled by Zentiva Group (a 95.9% ownership stake) which is in turn held by Advent International, also present in Romania with a drug plant in Bucharest (Sicomed). SCD shares have increased by 2% since the beginning of 2023, amid deals worth RON88,500, and by 4.2% over the last year, amid deals worth RON551,100, stock market data shows.
Zentiva ended 2022 with a net profit of RON89 million, down 15% versus 2021, and a turnover of RON753 million, up 10% on the year, as per data from the annual preliminary financial report published at the Bucharest Stock Exchange.